date:May 07, 2013
intermediate AMD. It is the largest trial to date testing the effectiveness of lutein, zeaxanthin and omega-3 in adults with AMD. The AREDS2 study also found that circulating blood levels of lutein and zeaxanthin increased significantly in those receiving supplements, which may have a protective effect in eye disease.
The results of AREDS2, which provides evidence that participants supplemented with 10 mg of FloraGLO Lutein and 2 mg of OPTISHARP Zeaxanthin have a reduced risk of developing adva